Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 StudyFrançoise Huguet, Hervé Dombret, Thibaut Leguay et al.|Journal of Clinical Oncology|2009Cited by 562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 TrialXavier Thomas, D Fière, Jean-Paul Vernant et al.|Journal of Clinical Oncology|2004Cited by 547
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 studyAdrienne de Labarthe, Hervé Dombret, Philippe Rousselot et al.|Blood|2006Cited by 345
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemiaKheïra Beldjord, Hervé Dombret, Sylvie Chevret et al.|Blood|2014Cited by 327
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trialEmmanuelle Tavernier, Xavier Thomas, JM Boiron et al.|Leukemia|2007Cited by 258